Literature DB >> 4332012

Persistence of a repressed Epstein-Barr virus genome in Burkitt lymphoma cells made resistant to 5-bromodeoxyuridine.

B Hampar, J G Derge, L M Martos, J L Walker.   

Abstract

The P3HR-1 line of human lymphoblastoid cells that is Epstein-Barr virus positive was made resistant to 5-bromodeoxyuridine. Epstein-Barr virus-associated antigens, but not virus particles, were produced in P3HR-1(BU) cells maintained on 5-bromodeoxyuridine. However, virus particles did appear within 4 days after removal of the drug. Thymidine kinase activity was limited to P3HR-1(BU) cells producing viral antigen, whereas all control P3HR-1 cells showed thymidine kinase activity regardless of viral antigen synthesis. Cellular DNA in most P3HR-1(BU) cells was made via pathways that did not involve thymidine kinase. In cells having a pathway that involved thymidine kinase, a second DNA of density 1.71 g/cm(3), corresponding to Epstein-Barr virus, was detected.IT WAS CONCLUDED THAT: (a) a repressed Epstein-Barr virus genome persists in P3HR-1(BU) cells that do not contain thymidine kinase, with activation of the viral genome being accompanied by productive infection and the appearance of enzyme, and (b) thymidine kinase activity in P3HR-1(BU) cells could be used as a marker for viral genome expression.

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 4332012      PMCID: PMC389618          DOI: 10.1073/pnas.68.12.3185

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  15 in total

1.  THE EFFECT OF 5-BROMODEOXYURIDINE ON HERPES SIMPLEX INFECTION OF HELA CELLS.

Authors:  P SIMINOFF
Journal:  Virology       Date:  1964-09       Impact factor: 3.616

2.  Epstein-Barr viral antigen in single cell clones of two human leukocytic lines.

Authors:  M H Miller; D Stitt; G Miller
Journal:  J Virol       Date:  1970-11       Impact factor: 5.103

3.  Incidence of EB virus-containing cells in primary and secondary clones of several Burkitt lymphoma cell lines.

Authors:  B A Maurer; S M Wilbert; T Imamura
Journal:  Cancer Res       Date:  1970-12       Impact factor: 12.701

4.  Partial purification of the Epstein-Barr virus and some properties of its DNA.

Authors:  H Schulte-Holthausen; H zur Hausen
Journal:  Virology       Date:  1970-03       Impact factor: 3.616

5.  Cloning of Burkitt lymphoma cells cultured in vitro.

Authors:  Y Hinuma; J T Grace
Journal:  Cancer       Date:  1968-12       Impact factor: 6.860

6.  Immunoferritin and immunofluorescent studies with Epstein-Barr virus and herpes simplex virus by use of human sera and hyperimmune rabbit sera.

Authors:  B Hampar; P Gerber; K C Hsu; L M Martos; J L Walker; R F Sigüenza; G A Wells
Journal:  J Natl Cancer Inst       Date:  1970-07       Impact factor: 13.506

7.  Replication of herpes-type virus in a Burkitt lymphoma cell line.

Authors:  Y Hinuma; M Konn; J Yamaguchi; J T Grace
Journal:  J Virol       Date:  1967-12       Impact factor: 5.103

8.  Characterization of the DNA of herpesviruses associated with Lucké adenocarcinoma of the frog and Burkitt lymphoma of man.

Authors:  E K Wagner; B Roizman; T Savage; P G Spear; M Mizell; F E Durr; D Sypowicz
Journal:  Virology       Date:  1970-09       Impact factor: 3.616

9.  Incorporation of 5-bromodeoxyuridine and 5-iododeoxyuridine into viral DNA and its effect on the infective process.

Authors:  A S Kaplan; T Benporat; T Kamiya
Journal:  Ann N Y Acad Sci       Date:  1965-07-30       Impact factor: 5.691

10.  Immunofluorescence and herpes-type virus particles in the P3HR-1 Burkitt lymphoma cell line.

Authors:  Y Hinuma; M Konn; J Yamaguchi; D J Wudarski; J R Blakeslee; J T Grace
Journal:  J Virol       Date:  1967-10       Impact factor: 5.103

View more
  15 in total

1.  Utilization of cultured human lymphoid cells for detection of humoral sensitization in prospective recipients of kidney transplants.

Authors:  S Ferrone; A Ting; M A Pellegrino; P I Terasaki; R A Reisfeld
Journal:  J Clin Invest       Date:  1975-02       Impact factor: 14.808

Review 2.  Oncogenic properties of human viruses.

Authors:  R Glaser; B Decker; F Rapp
Journal:  In Vitro       Date:  1975 May-Jun

3.  Assay for Epstein-Barr virus based on stimulation of DNA synthesis in mixed leukocytes from human umbilical cord blood.

Authors:  J Robinson
Journal:  J Virol       Date:  1975-05       Impact factor: 5.103

4.  Stimulation of adenovirus replication in simian cells in the absence of a helper virus by pretreatment of the cells with iododeoxyuridine.

Authors:  M Jerkofsky; F Rapp
Journal:  J Virol       Date:  1975-02       Impact factor: 5.103

5.  Immunofluorescence microscopy and flow cytometry characterization of chemical induction of latent Epstein-Barr virus.

Authors:  H B Jenson; G M Grant; Y Ench; P Heard; C A Thomas; S G Hilsenbeck; M P Moyer
Journal:  Clin Diagn Lab Immunol       Date:  1998-01

6.  DNA polymerase activities in differentiating mouse neuroblastoma N-18 cells.

Authors:  P Bhattacharya; S Basu
Journal:  Proc Natl Acad Sci U S A       Date:  1978-03       Impact factor: 11.205

7.  Activation of Epstein-Barr virus by 5-bromodeoxyuridine in "virus-free" human cells (complement-fixing antigen-immunofluorescence-leukocytes).

Authors:  P Gerber
Journal:  Proc Natl Acad Sci U S A       Date:  1972-01       Impact factor: 11.205

8.  Synthesis of Epstein-Barr virus after activation of the viral genome in a "virus-negative" human lymphoblastoid cell (Raji) made resistant to 5-bromodeoxyuridine (thymidine kinase-virus antigen-immunofluorescence-herpesvirus fingerprints).

Authors:  B Hampar; J G Derge; L M Martos; J L Walker
Journal:  Proc Natl Acad Sci U S A       Date:  1972-01       Impact factor: 11.205

9.  Replication of the resident repressed Epstein-Barr virus genome during the early S phase (S-1 period) of nonproducer Raji cells.

Authors:  B Hampar; A Tanaka; M Nonoyama; J G Derge
Journal:  Proc Natl Acad Sci U S A       Date:  1974-03       Impact factor: 11.205

10.  Effect of dibutyryl cyclic AMP on the induction of Epstein-Barr virus in hybrid cells.

Authors:  J E Zimmerman; R Glaser; F Rapp
Journal:  J Virol       Date:  1973-12       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.